House Over­sight Com­mit­tee opens probe in­to FDA's han­dling of drug short­ages

Re­pub­li­can rep­re­sen­ta­tives lead­ing the House Com­mit­tee on Over­sight and Ac­count­abil­i­ty to­day an­nounced an in­ves­ti­ga­tion in­to FDA’s re­sponse to crit­i­cal US drug short­ages, in­clud­ing com­mon can­cer drugs and an­tibi­otics.

Over­sight Com­mit­tee Chair James Com­er (R-KY) and Health Sub­com­mit­tee Chair Lisa Mc­Clain (R-MI) said they’re con­cerned by the 128 drugs list­ed by the FDA as be­ing in short­age, in­clud­ing com­mon­ly used ones to treat in­fec­tions, can­cer, psy­chi­atric con­di­tions and heart fail­ure.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER